Catalyst Wire Dossier Catalyst Wire Dossier

SGLT2 inhibitor

Drug timelines are a Plus or Pro feature.

54 regulatory and trial events tracked for SGLT2 inhibitor, covering 2018-05-08 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus [Phase 3]

See pricing